Medtronic PLC vs Global X Defense Tech ETF — how do they compare? Medtronic PLC trades at $83.14 (market cap $106.50B), while Global X Defense Tech ETF trades at $60.02. The key difference: Medtronic PLC pays a 3.46% dividend while Global X Defense Tech ETF pays none, and Medtronic PLC is trading nearer its 52-week high, Global X Defense Tech ETF nearer its low. Which is the better fit depends on your goals.
| MDT | SHLD | |
|---|---|---|
Market Cap | $106.50B | — |
Sector | Health | Sector/Thematic |
52-Week High | $105.35 | $78.02 |
52-Week Low | $73.75 | $58.20 |
Enterprise Value | $125.24B | — |
Dividend Yield | 3.46% | — |
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $83.20, down 0.43% on the day, with strong technical support at $83 and resistance at $85. The company demonstrates solid fundamentals with revenue growth to $33.54 billion in 2025 and consistent earnings beats, including Q1 2026 EPS of $1.55 beating expectations. Recent acquisitions of SPR and Scientia Vascular expand the company's pain therapy and neurovascular portfolios, positioning for future growth.
MDT presents an attractive investment opportunity with 58% analyst buy ratings and a $97.50 consensus price target representing 17% upside. The dividend aristocrat offers income stability with a $0.72 semi-annual dividend. Key risks include rising debt levels and competitive pressures in medical technology. The stock's current valuation at 22.31 P/E appears reasonable given growth prospects and market leadership.
SHLD trades at $60.06, up 0.28% today, but technical indicators show a bearish trend with moving averages signaling sell pressure. The ETF offers exposure to global defense technology stocks amid rising military budgets. Recent news highlights institutional interest and geopolitical tailwinds supporting the defense sector, though financial ratios are currently unavailable for valuation assessment.
Outlook remains mixed: bullish sentiment from defense spending trends and potential technical rebound contrasts with bearish technical signals and valuation opacity. Key risks include geopolitical shifts and expense ratio comparisons with peers. Investors should weigh sector growth against ETF-specific metrics and market volatility.
Trailing returns across standard periods
Latest headlines on both assets
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →SHLD tracks the Global X Defense Tech Index, targeting companies that lead the technological transformation of the defense sector. It focuses on pure-play innovators in cybersecurity, artificial intelligence, robotics, and advanced military systems, excluding traditional commercial aerospace to maintain a high level of thematic purity.
Read more on SHLD →